logo

News

    • 13TH APRIL 2023

    Medicine Supply Notification: Estradiol (Estradot® ) 75micrograms/24hours transdermal patches

    Department of Health and Social Care (DHSC) has issued a medicine supply notification for Estradiol (Estradot®) 75micrograms/24hours transdermal patches. MSN/2023/047 Tier 2 – medium impact Date of issue 13th April 2023 Estradiol (Estradot®) 75micrograms/24hours transdermal patches are out of stock until early May 2023. An alternative brand of estradiol patches, Evorel®, available as 75micrograms/24hours can

    Read more
    • 13TH APRIL 2023

    SSP issued for Estradot® 75mcg patches

    In response to a significant ongoing disruption to the supply of Estradot® 75micrograms/24hours patches, a Serious Shortage Protocol (SSP) has been issued by the Department of Health and Social Care (DHSC). Effective today, 13 April 2023, SSP055 provides that for every Estradot® 75micrograms/24hours patch originally prescribed, one Evorel® 75 patch must be supplied. SSP055, authorised by the Secretary

    Read more
    • 13TH APRIL 2023

    NHSE announces contraception service launch

    NHS England (NHSE) has announced that the Pharmacy Contraception Service will launch from 24th April 2023.  This start date for the service has not been agreed with PSNC and is in direct contradiction of our warning to Ministers that no new or expanded services can be rolled out in 2023/24 unless extra funding is put

    Read more
    • 13TH APRIL 2023

    Pressures Survey confirms rising costs, patient demand and medicine supply issues continue to grip community pharmacy

    PSNC’s 2023 Pharmacy Pressures Survey has confirmed the worsening situation for community pharmacies as rising costs and significantly increased workload is putting businesses at greater risk of collapse. The survey of over 6,200 pharmacy premises and 2,000 pharmacy team members shows a very worrying picture of the impact of the current pressures on pharmacies and

    Read more
    • 12TH APRIL 2023

    Medicine Supply Notification: Alfuzosin 10mg modified release tablets

    Department of Health and Social Care (DHSC) has issued a medicine supply notification for Alfuzosin 10mg modified release tablets. MSN/2023/045 Tier 2 – medium impact Date of issue 12th April 2023 There is limited supply of alfuzosin 10mg modified release tablets until w/c 15th May 2023. Alternative alpha-adrenoceptor blockers licensed for the symptomatic treatment of

    Read more
    • 12TH APRIL 2023

    Share your views on the Pharmacy Quality Scheme

    Community pharmacy contractors (including head office staff) and community pharmacists are invited to participate in an interview to share their views on the Quality Payments Scheme (QPS) (the previous name for the Pharmacy Quality Scheme (PQS)) and the PQS. ICF (an independent research consultancy) and the University of Manchester are carrying out the evaluation. The

    Read more
    • 11TH APRIL 2023

    Chance to share your views – EPS outcomes and trackability survey

    PSNC, working with Kingston University and the Community Pharmacy IT Group (CP ITG), has launched a short survey to gather feedback about EPS Paperless, Outcomes and Trackability. Please complete the short EPS survey here We would appreciate views from community pharmacy teams,  including those working within multiple group head offices, who are requested to complete

    Read more
    • 6TH APRIL 2023

    Medicine Supply Notification: Clarithromycin 125mg/5ml and 250mg/5ml oral suspensions

    Department of Health and Social Care (DHSC) has issued a medicine supply notification for Clarithromycin 125mg/5ml and 250mg/5ml oral suspensions. MSN/2023/044 Tier 2 – medium impact Date of issue 6th April 2023 Clarithromycin 125mg/5ml oral suspension is out of stock until w/c 10th April 2023 Clarithromycin 250mg/5ml oral suspension is in limited supply until w/c

    Read more
    • 6TH APRIL 2023

    Medicine Supply Notification: Estriol (Imvaggis® ) 0.03mg pessary

    Department of Health and Social Care (DHSC) has issued a medicine supply notification for Estriol (Imvaggis®) 0.03mg pessary. MSN/2023/041 Tier 2 – medium impact Date of issue 6th April 2023 Estriol (Imvaggis®) 0.03mg pessary is out of stock until mid-late May 2023 Alternative estriol vaginal products remain available, as does estradiol 10mcg vaginal tablets, and

    Read more
    • 6TH APRIL 2023

    Medicine Supply Notification: Oxycodone Hydrochloride 5mg/5ml Oral Solution

    Department of Health and Social Care (DHSC) has issued a medicine supply notification for Oxycodone Hydrochloride 5mg/5ml Oral Solution. MSN/2023/042 Tier 2 – medium impact Date of issue 6th April 2023 Wockhardt is out of stock oxycodone 5mg/5ml oral solution until end of June 2023. Oxycodone 5mg/5ml oral solution from other manufacturers remains available but

    Read more
© 2025 Middlesex Pharmaceutical Group